Literature DB >> 7986895

Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome.

J B Haug1, S Harthug, T Kalager, A Digranes, C O Solberg.   

Abstract

All episodes of bloodstream infection in patients admitted to a Norwegian university hospital in 1974-1979 and in 1988-1989 were analyzed; altogether, there were 1,447 episodes involving 1,286 patients, and 54.3% of all episodes were hospital-acquired. The incidence of bloodstream infection increased between the two periods studied from 4.26/1,000 admissions to 8.71/1,000. Crude mortality rates were 27.6% and 18.8% and attributable mortality rates were 12.3% and 6.9% in the first and second periods, respectively. Patients > 60 years of age accounted for more than half of the bloodstream infections; mortality in this group was significantly higher than that among younger patients (31.4% vs. 13.9%). The frequency of isolation of Enterobacteriaceae decreased from 48% in the first period to 34% in the second, while the rate of isolation of coagulase-negative staphylococci increased from 6.5% to 16.9%. The shift in etiology may be explained in part by the occurrence of significantly more bloodstream infections related to intravascular devices, endocarditis, and skin and wound infections and of significantly fewer episodes related to abdominal or genitourinary disease in the second than in the first period. Almost all isolates of Enterobacteriaceae were susceptible to newer cephalosporins and aminoglycosides. In 1974-1979, 96 (69.1%) of 139 patients with septic shock died; in 1988-1989, the figure was 35 (52.2%) of 67 patients (P = .019). Clinical factors predictive of an adverse outcome were septic shock (odds ratio for first/second period, 12.7/4.6), intensive care treatment (not significant/10.6), malignant disease (4.6/2.6), any underlying disease (4.2/not significant), diabetes mellitus (3.6/not significant), age of > 60 years (not significant/3.0), and pulmonary source of infection (not significant/2.8).

Entities:  

Mesh:

Year:  1994        PMID: 7986895     DOI: 10.1093/clinids/19.2.246

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

Review 1.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

2.  Case mortality in polymicrobial bloodstream infections.

Authors:  F E McKenzie
Journal:  J Clin Epidemiol       Date:  2006-05-02       Impact factor: 6.437

3.  Diabetes mellitus is an independent risk factor for ICU-acquired bloodstream infections.

Authors:  M Michalia; M Kompoti; A Koutsikou; A Paridou; P Giannopoulou; E Trikka-Graphakos; P Clouva-Molyvdas
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

4.  Prognostic factors associated with improved outcome of Escherichia coli bacteremia in a Finnish university hospital.

Authors:  A Kuikka; A Sivonen; A Emelianova; V V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-02       Impact factor: 3.267

Review 5.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

6.  Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center.

Authors:  E Velasco; R Byington; C A S Martins; M Schirmer; L M C Dias; V M S C Gonçalves
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

7.  Existing data sources for clinical epidemiology: The North Denmark Bacteremia Research Database.

Authors:  Henrik C Schønheyder; Mette Søgaard
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

8.  Glucose directly promotes antifungal resistance in the fungal pathogen, Candida spp.

Authors:  Santi M Mandal; Denial Mahata; Ludovico Migliolo; Aditya Parekh; Partha S Addy; Mahitosh Mandal; Amit Basak
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

9.  Bacterial and Lyme Arthritis.

Authors:  John J Ross; Linden T Hu
Journal:  Curr Infect Dis Rep       Date:  2004-10       Impact factor: 3.725

10.  Rapid identification and antimicrobial susceptibility profiling of Gram-positive cocci in blood cultures with the Vitek 2 system.

Authors:  A Lupetti; S Barnini; B Castagna; A-L Capria; P H Nibbering
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-10       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.